Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The International Journal of Tuberculosis and Lung Disease

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5588/ijtld.16.0779PMID 28399971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dilemma of managing asymptomatic children referred with ‘culture-confirmed’ drug-resistant tuberculosis

  2016cited by this paper
• Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis

  2016cited by this paper
• Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.

  2015cited by this paper
• Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

  2015cited by this paper
• Completeness and Reliability of the Republic of South Africa National Tuberculosis (TB) Surveillance System

  2015cited by this paper
• Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

  2014cited by this paper
• Why tuberculosis service providers do not follow treatment guideline in Ethiopia: a qualitative study.

  2014cited by this paper
• What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?

  2013cited by this paper
• Chest Radiograph Findings and Time to Culture Conversion in Patients with Multidrug-Resistant Tuberculosis and HIV in Tugela Ferry, South Africa

  2013cited by this paper
• Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India

  2012cited by this paper
• Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

  2012cited by this paper
• Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal.

  2012cited by this paper
• Accuracy and completeness of recording of confirmed tuberculosis in two South African communities.

  2011cited by this paper
• High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening

  2011cited by this paper
• Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis.

  2010cited by this paper
• Eliminating latent tuberculosis.

  2009cited by this paper
• A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance.

  2008cited by this paper
• Childhood pulmonary tuberculosis: old wisdom and new challenges.

  2006cited by this paper
• The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

  2004cited by this paper
• Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

  1999cited by this paper

• An Evaluation of Programmatic Community-Based Chest X-ray Screening for Tuberculosis in Ho Chi Minh City, Vietnam

  2020cites this paper
• Loss to Follow-Up (LTFU) during Tuberculosis Treatment

  2019cites this paper
• Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis

  2018cites this paper